A Family Legacy: Improving Global Public Health


When Dr. Charles A. Knirsch, MD, MPH, joined Pfizer more than 20 years ago, planning had just begun for a new partnership to eliminate trachoma, a neglected tropical disease and the world’s leading infectious cause of blindness.

An Intervention That Can Significantly Improve Child Health


The New England Journal of Medicine has published results from a new study showing that the use of an antibiotic significantly reduced mortality among children living in three low-income countries in Sub-Saharan Africa.

Novel Novartis Compound Shows Potential as Effective Therapy for Treating Drug Resistant Malaria

Results published in the New England Journal of Medicine
Press Release
  • Results published in the New England Journal of Medicine demonstrate that
    KAF156 shows activity against blood and liver stages of malaria parasites, including artemisinin-resistant parasites

  • KAF156, currently in phase IIb, is the first compound from a novel class of antimalarials known as imidazolopiperazines

Subscribe to NEJM